A racemate comprising equimolar amounts of (R)- and (S)-Fasnall. Both enantiomers act as fatty acid synthase inhibitors, although the (S)-enantiomer was found to be more than 4 times as active as the (R)-enantiomer.
Machine-generated and unreviewed. Identity, structure and cross-references come straight from ChEBI's and CARD's own data; no curator has signed off on this record yet.
CHEBI:60911| Molecular formula | C19H22N4S |
|---|---|
| Charge | 0 |
| Average mass | 338.48 Da |
| Monoisotopic mass | 338.15652 Da |
| Source | ChEBI |
| InChIKey | VSXRMURGJRAOCU-UHFFFAOYSA-N |
Cc1sc2ncnc(NC3CCN(Cc4ccccc4)C3)c2c1C
InChI=1S/C19H22N4S/c1-13-14(2)24-19-17(13)18(20-12-21-19)22-16-8-9-23(11-16)10-15-6-4-3-5-7-15/h3-7,12,16H,8-11H2,1-2H3,(H,20,21,22)
CHEBI:64946| Source | Native ID | Label | Minted CURIE | Version |
|---|---|---|---|---|
| CHEBI | CHEBI:145520 |
Fasnall | antibioticmech:chebi-df32b02391 |
2026-08-30 |
Seeded from data/raw/ inventories (CHEBI)
Re-seeded from updated data/raw/ inventories
Re-seeded from updated data/raw/ inventories